MjLink

Medical Cannabis Gummy Dosages On the Rise in Texas - MjLink Cannabis Business News and Press

MjLink Cannabis Business News and Press

Cannabis Industry Business Professionals Blogs, Press Releases and News Articles from the best journalist in the industry. Stay updated on all news from many online cannabis news outlets, on MjLink.com

Medical Cannabis Gummy Dosages On the Rise in Texas

Cannabis Business Times Marijuana News Wednesday, 23 February 2022
2 minutes reading time (317 words)
One of the biggest cannabis companies in Texas now has the highest-dosage medical cannabis product available on the state’s market.

Texas Original Compassionate Cultivation expanded its gummy lineup to now include 20-milligram THC units, the highest dosage allowed under the state’s recently updated program.

The new product dosage was approved during last year’s legislative session, when state lawmakers also expanded qualifying conditions—to include cancer patients and those with post-traumatic stress disorder—and raised the THC limit for medical cannabis from 0.5% to 1%.

RELATED: Texas Cancer Patients, Those With PTSD Gear Up For Medical Cannabis Access

Offering stronger products will benefit the state’s medical cannabis patients, many of whom are veterans or suffering from cancer, Texas Original CEO Morris Denton told NBC-affiliate KNAX.

“We needed to make a stronger product that would allow them to get to their target dose as prescribed by their doctor, without consuming a whole lot of byproducts,” he said.

Texas Original’s new product is a THC-only gummy—debuting with a strawberry passionfruit flavor—which the company describes as fast-acting to offer patients a more efficient treatment option to mitigate symptoms such as pain, insomnia, night terrors and nausea, according to the company’s press release.

Ahead of the gummies’ launch, Texas Original conducted a trial with PTSD patients to evaluate the product’s efficacy and onset, as well as the overall patient experience. According to the company, the majority of the study’s participants use medical cannabis to counteract pain, insomnia and anxiety.

“The feedback from our patients and physicians about Texas Original’s 20-mg gummies has been overwhelmingly positive,” Denton said in the release. “Patients are experiencing smooth, lasting effects with a quicker onset and are leaving their heavy, traditional pharmaceuticals behind.”

Trial participants unanimously reported symptom alleviation from the new product, and also indicated that the 20-milligram dosage allowed them to ingest less product to reach their prescribed amounts of THC faster, according to the company.

]]>

  • Previous
  • Next

About the author

Cannabis Business Times

Author's recent posts
More posts from author
Monday, 03 November 2025 Closing Farm Bill ‘Loophole’ Would Help Hemp Industry ‘Thrive,’ Minnesota AG Says
Monday, 03 November 2025 Borealis Opens State-of-the-Art Cultivation, Production Facility in Connecticut
Monday, 03 November 2025 InterCure, Cannasoul Partner to Advance Cannabis Science, Pharmaceutical Innovation
Monday, 03 November 2025 Curaleaf Launches 5th Annual 'Feed the Block' Fundraiser to Combat Food Insecurity in US
Monday, 03 November 2025 Planet 13 Divests California Dispensary, Closes Cultivation Facility
Monday, 03 November 2025 Cannabis Consumer Survey Shows Digital Conveniences Driving Purchasing

Related Posts

Closing Farm Bill ‘Loophole’ Would Help Hemp Industry ‘Thrive,’ Minnesota AG Says

Marijuana News

Borealis Opens State-of-the-Art Cultivation, Production Facility in Connecticut

Marijuana News

InterCure, Cannasoul Partner to Advance Cannabis Science, Pharmaceutical Innovation

Marijuana News

Curaleaf Launches 5th Annual 'Feed the Block' Fundraiser to Combat Food Insecurity in US

Marijuana News

Planet 13 Divests California Dispensary, Closes Cultivation Facility

Marijuana News

Cannabis Consumer Survey Shows Digital Conveniences Driving Purchasing

Marijuana News

Copyright ©2026 MjLink


main version